Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Agata Marjańska"'
Autor:
Agata Marjańska, Monika Pogorzała, Magdalena Dziedzic, Krzysztof Czyżewski, Monika Richert-Przygońska, Robert Dębski, Tomasz Bogiel, Jan Styczyński
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundChildren undergoing allo-HCT are at high risk of EBV-related complications. The objective of the study was to analyze the impact of prophylactic post-transplant rituximab on EBV infection and EBV-PTLD in children after allo-HCT, to determin
Externí odkaz:
https://doaj.org/article/d1d749b9b5474b2480ad3d85876c57da
Autor:
Magdalena Dziedzic, Agata Marjańska, Katarzyna Bąbol-Pokora, Anna Urbańczyk, Elżbieta Grześk, Wojciech Młynarski, Sylwia Kołtan
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 15, Iss 1, Pp 1-6 (2017)
Abstract Background Pediatric autoinflammatory diseases are rare and still poorly understood conditions resulting from defective genetic control of innate immune system, inter alia from anomalies of NOD2 gene. The product of this gene is Nod2 protein
Externí odkaz:
https://doaj.org/article/e67ad6cc1f6b41f3b24bc59fd22f18f8
Autor:
Joanna Stankiewicz, Andrzej Kołtan, Ewa Demidowicz, Natalia Bartoszewicz, Sylwia Kołtan, Krzysztof Czyżewski, Monika Richert-Przygońska, Robert Dębski, Monika Pogorzała, Barbara Tejza, Joanna Cisek, Piotr Księżniakiewicz, Agnieszka Jatczak-Gaca, Agata Marjańska, Marlena Salamon, Anna Dąbrowska, Anna Urbańczyk, Elżbieta Grześk, Kamila Jaremek, Monika Łęcka, Oliwia Grochowska, Jan Styczyński
Publikováno v:
Annals of Hematology.
Therapy results in pediatric Hodgkin lymphoma reflect remarkable progress in pediatric oncology. In the last decade, relevant development of new therapeutic options for children with refractory or relapsed disease has been made. In this study, we ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6634c1d6091bc8e0da21019188b00a90
https://doi.org/10.1007/s00277-023-05268-5
https://doi.org/10.1007/s00277-023-05268-5
Autor:
Joanna Stankiewicz, Ewa Demidowicz, Agnieszka Jatczak-Gaca, Natalia Bartoszewicz, Andrzej Kołtan, Sylwia Kołtan, Krzysztof Czyżewski, Monika Richert-Przygońska, Robert Dębski, Monika Pogorzała, Barbara Tejza, Piotr Księżniakiewicz, Joanna Cisek, Marlena Ewertowska, Agata Marjańska, Anna Dąbrowska, Anna Urbańczyk, Elżbieta Grześk, Kamila Jaremek, Eugenia Winogrodzka, Dominika Kołuda, Monika Łęcka, Monika Adamkiewicz, Sandra Wałach, Oliwia Grochowska, Sonia Tarasenko, Marta Mazalon, Magdalena Dziedzic, Małgorzata Kubicka, Beata Kuryło-Rafińska, Ewa Dembna, Agnieszka Majk, Mariusz Wysocki, Jan Styczyński
Publikováno v:
Acta Haematologica Polonica.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0989dec66ba3d696842aa822e1165596
https://doi.org/10.5603/ahp.a2023.0003
https://doi.org/10.5603/ahp.a2023.0003
Autor:
Marlena Ewertowska, Agnieszka Jatczak-Gaca, Hanna Żołnowska, Anna Dąbrowska, Robert Dębski, Monika Łęcka, Barbara Tejza, Natalia Bartoszewicz, Anna Urbańczyk, Elżbieta Grześk, Andrzej Kołtan, Magdalena Dziedzic, Mariusz Wysocki, Agata Marjańska, Ewa Demidowicz, Sylwia Kołtan, Piotr Księżniakiewicz, Monika Pogorzała, Krzysztof Czyżewski, Joanna Cisek, Przemysław Gałązka, Jan Styczyński, Monika Richert-Przygońska
Publikováno v:
Acta Haematologica Polonica. 52:483-492
Introduction: We analyzed the epidemiology and outcomes of treatment of invasive fungal disease (IFD) in children during anticancer therapy (PHO, pediatric hematology and oncology) or after hematopoietic cell transplantation (HCT) over a period of ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a170468708818c6c776f39cda0a03827
https://doi.org/10.5603/ahp.a2021.0025
https://doi.org/10.5603/ahp.a2021.0025
Autor:
Marlena Ewertowska, Robert Dębski, Elżbieta Grześk, Agnieszka Jatczak-Gaca, Piotr Księżniakiewicz, Mariusz Wysocki, Anna Dąbrowska, Joanna Cisek, Magdalena Dziedzic, Anna Urbańczyk, Sylwia Kołtan, Monika Pogorzała, Monika Richert-Przygońska, Krzysztof Czyżewski, Natalia Bartoszewicz, Agata Marjańska, Hanna Żołnowska, Monika Łęcka, Anna Krenska, Jan Styczyński, Barbara Tejza, Andrzej Kołtan, Ewa Demidowicz
Publikováno v:
Acta Haematologica Polonica. 51:164-171
IntroductionLeukemia belong to 31% of all childhood malignancies. Acute lymphoblastic leukemia (ALL) is the most frequent type of pediatric leukemia accounting for 80–85% of all cases. Progress in diagnostics and therapy of leukemia is dependent on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25c6011f594574b6c1d38996b995e430
https://doi.org/10.2478/ahp-2020-0029
https://doi.org/10.2478/ahp-2020-0029
Publikováno v:
Acta Haematologica Polonica. 51:102-107
Background/AimNeurofibromatosis type 1 (NF1) is characterized by the occurrence of multisystem tumors. The objective of this study was to analyze the demographic and oncological profile of 830 NF1-individuals regarding prevalence, type, and spectrum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f56a577a3275c872f1016ad6dcf003c
https://doi.org/10.2478/ahp-2020-0019
https://doi.org/10.2478/ahp-2020-0019
Autor:
Krzysztof Czyżewski, Jan Styczyński, Agata Marjańska, Irena Daniluk-Matras, Przemyslaw Galazka
Publikováno v:
Anticancer Research. 39:5853-5859
Background/aim The objective of the study was to propose clinical guidelines for the use of minimally invasive surgery (MIS) in pediatric oncology. Patients and methods Two groups of experts, including pediatric surgeons and pediatric oncologists wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083a0f8f3a356060bf0182a81adbb0a0
https://doi.org/10.21873/anticanres.13789
https://doi.org/10.21873/anticanres.13789
Autor:
Agata Marjańska, Jan Styczyński, Hanna Żołnowska, Andrzej Kołtan, Malgorzata Kubicka, Monika Pogorzała, Krzysztof Czyżewski, Robert Dębski, Beata Kuryło-Rafińska, Ewa Demidowicz, Monika Łęcka, Monika Richert-Przygońska
Publikováno v:
Anticancer Research. 39:5203-5207
Background A retrospective analysis was performed to investigate the survival outcomes in pediatric acute lymphoblastic leukemia (ALL) based on time period. We hypothesized that improvement has been obtained with the time-dependent therapeutic era an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78633336662e24f8c6b68e4b68680333
https://doi.org/10.21873/anticanres.13717
https://doi.org/10.21873/anticanres.13717
Autor:
Wojciech MŁynarski, Walentyna Balwierz, Katarzyna PawiŃska-WĄsikowska, Anna Raciborska, Agata MarjaŃska, Mariusz Wysocki, Katarzyna Bobeff, BoŻenna Dembowska-BagiŃska, Agnieszka Mizia-Malarz, Monika Drogosiewicz, Jan StyczyŃski
Publikováno v:
Anticancer research. 40(12)
Background/aim Nivolumab is an immune checkpoint inhibitor with high antitumor activity in selected neoplasms. The aim of the study was to evaluate the efficacy and safety of nivolumab in pediatric patients with various types of highly malignant adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::249176a4f4fed5f2e5041997e75e56a2
https://pubmed.ncbi.nlm.nih.gov/33288608
https://pubmed.ncbi.nlm.nih.gov/33288608